Businesses are questioning the value of heavy AI investments, as seen in a pharmaceutical company canceling AI-powered software due to lack of added value and demand.
There's skepticism over whether the significant expenditures by big tech on AI infrastructure will align with actual demand and generate expected returns, with concerns raised during earnings calls.
Collection
[
|
...
]